Cargando…
SMAD6-deficiency in human genetic disorders
SMAD6 encodes an intracellular inhibitor of the bone morphogenetic protein (BMP) signalling pathway. Until now, SMAD6-deficiency has been associated with three distinctive human congenital conditions, i.e., congenital heart diseases, including left ventricular obstruction and conotruncal defects, cr...
Autores principales: | Luyckx, Ilse, Verstraeten, Aline, Goumans, Marie-José, Loeys, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681871/ https://www.ncbi.nlm.nih.gov/pubmed/36414630 http://dx.doi.org/10.1038/s41525-022-00338-5 |
Ejemplares similares
-
Hide and seek: Somatic SMAD3 mutations in melorheostosis
por: Velchev, Joe Davis, et al.
Publicado: (2020) -
The emerging role of endothelial cells in the pathogenesis of thoracic aortic aneurysm and dissection
por: Verstraeten, Aline, et al.
Publicado: (2023) -
The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2
por: Peeters, Silke, et al.
Publicado: (2022) -
Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier
por: Perik, Melanie H. A. M., et al.
Publicado: (2023) -
Genetic disorders coupled to ROS deficiency
por: O’Neill, Sharon, et al.
Publicado: (2015)